A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.

Strong evidence of linkage to late-onset Alzheimer disease (LOAD) has been observed on chromosome 10, which implicates a wide region and at least one disease-susceptibility locus. Although significant associations with several biological candidate genes on chromosome 10 have been reported, these findings have not been consistently replicated, and they remain controversial. We performed a chromosome 10-specific association study with 1,412 gene-based single-nucleotide polymorphisms (SNPs), to identify susceptibility genes for developing LOAD. The scan included SNPs in 677 of 1,270 known or predicted genes; each gene contained one or more markers, about half (48%) of which represented putative functional mutations. In general, the initial testing was performed in a white case-control sample from the St. Louis area, with 419 LOAD cases and 377 age-matched controls. Markers that showed significant association in the exploratory analysis were followed up in several other white case-control sample sets to confirm the initial association. Of the 1,397 markers tested in the exploratory sample, 69 reached significance (P < .05). Five of these markers replicated at P < .05 in the validation sample sets. One marker, rs498055, located in a gene homologous to RPS3A (LOC439999), was significantly associated with Alzheimer disease in four of six case-control series, with an allelic P value of .0001 for a meta-analysis of all six samples. One of the case-control samples with significant association to rs498055 was derived from the linkage sample (P = .0165). These results indicate that variants in the RPS3A homologue are associated with LOAD and implicate this gene, adjacent genes, or other functional variants (e.g., noncoding RNAs) in the pathogenesis of this disorder.

[1]  S. Seligman.  Methicillin-resistant staphylococci: genetics of the minority population. , 1966, Journal of general microbiology.

[2]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[3]  S. Sorbi.  Molecular genetics of Alzheimer’s disease , 1993, Aging.

[4]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[5]  J. Booth,et al.  Resampling-Based Multiple Testing. , 1994 .

[6]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[7]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[8]  J. Haines,et al.  Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. , 1997, JAMA.

[9]  H. Narita,et al.  Characteristics of quinolone-induced small colony variants in Staphylococcus aureus. , 1997, The Journal of antimicrobial chemotherapy.

[10]  R. Proctor,et al.  A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly , 1997, Journal of bacteriology.

[11]  R. Proctor,et al.  Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Price,et al.  Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. , 1998, Archives of neurology.

[13]  A. Paterson,et al.  Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. , 1998, JAMA.

[14]  H. Schaller,et al.  Identification and characterization of SorCS, a third member of a novel receptor family. , 1999, Biochemical and biophysical research communications.

[15]  M. Owen,et al.  A full genome scan for late onset Alzheimer's disease , 1999 .

[16]  P. M. Conneally,et al.  Identification of Novel Genes in Late-Onset Alzheimer's Disease , 2000, Experimental Gerontology.

[17]  M. Owen,et al.  Susceptibility locus for Alzheimer's disease on chromosome 10. , 2000, Science.

[18]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[19]  E. Boerwinkle,et al.  Cladistic structure within the human Lipoprotein lipase gene and its implications for phenotypic association studies. , 2000, Genetics.

[20]  K. Crandall,et al.  TCS: a computer program to estimate gene genealogies , 2000, Molecular ecology.

[21]  J. Blangero,et al.  Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2000, Science.

[22]  M. Minden,et al.  Regulation of drug sensitivity by ribosomal protein S3a. , 2000, Blood.

[23]  S. Germer,et al.  High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. , 2000, Genome research.

[24]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[25]  U. Pettersson,et al.  Investigation of the functional effect of monoamine oxidase polymorphisms in human brain , 2001, Human Genetics.

[26]  S. Sakamoto,et al.  Inhibition of poly(ADP-ribose) polymerase activity by Bcl-2 in association with the ribosomal protein S3a. , 2002, Biochemistry.

[27]  R. Taléns-Visconti,et al.  Small-Colony Mutants of Staphylococcus aureus Allow Selection of Gyrase-Mediated Resistance to Dual-Target Fluoroquinolones , 2002, Antimicrobial Agents and Chemotherapy.

[28]  Steuart Rorke,et al.  Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness , 2002, Nature.

[29]  P. François,et al.  Increased Expression of Clumping Factor and Fibronectin-Binding Proteins by hemB Mutants of Staphylococcus aureus Expressing Small Colony Variant Phenotypes , 2002, Infection and Immunity.

[30]  Laurent Essioux,et al.  Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population. , 2002, Human molecular genetics.

[31]  M. Owen,et al.  Full genome screen for Alzheimer disease: stage II analysis. , 2002, American journal of medical genetics.

[32]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[33]  M. Albert,et al.  Results of a high-resolution genome screen of 437 Alzheimer's disease families. , 2003, Human molecular genetics.

[34]  L. Farrer,et al.  Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. , 2003, Human molecular genetics.

[35]  K. Becker,et al.  Evaluation of Different Methods To Detect Methicillin Resistance in Small-Colony Variants of Staphylococcus aureus , 2004, Journal of Clinical Microbiology.

[36]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Owen,et al.  Variation in the urokinase‐plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[38]  H. Schaller,et al.  The three sorCS genes are differentially expressed and regulated by synaptic activity , 2004, Journal of neurochemistry.

[39]  Steven J. Schrodi,et al.  Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Taylor J. Maxwell,et al.  Association studies between risk for late‐onset Alzheimer's disease and variants in insulin degrading enzyme , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[41]  M. Owen,et al.  Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease , 2005, Human mutation.

[42]  G. Peters,et al.  Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Associated with Extensive Alterations in Regulator and Virulence Gene Expression Profiles , 2005, Infection and Immunity.

[43]  G. Fadda,et al.  Recurrent ventriculoperitoneal shunt infection caused by small-colony variants of Staphylococcus aureus. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  David V Conti,et al.  A testing framework for identifying susceptibility genes in the presence of epistasis. , 2006, American journal of human genetics.

[45]  M. Owen,et al.  α-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer’s disease , 2007, NeuroMolecular Medicine.